The World Influenza Congress Europe - The big idea

Pandemic reality reignites influenza vaccine market
Even before the onset of the global influenza pandemic, over the past five years, government spending worldwide on pandemic influenza preparedness had more than tripled from €1.6 billion in 2004 to €5 billion in 2009. Forecasts now predict worldwide government spending will continue to grow beyond €7 billion by 2013.

By next year alone, it is expected that of this €5 billion market segment, influenza vaccines will account for approx. 60% of total revenues in this sector, strengthening the industry’s’ reputation as the primary delivery mechanism for the treatment and prevention of influenza.

Fueling this sector growth, and understandably in line with domestic healthcare strategies, governments globally are continuing to show an overwhelming display of support and funding for many pandemic influenza research programs, product development and pandemic prevention and/or control that tackles this current influenza pandemic. Meeting the challenge of pandemic vaccine response remains a key strategy that is being carried out across the industry amongst pharma, biotech and service sector profiles in their H1N1 R&D programmes.

However if global challenges are to be met industry must look to combine facilitating vaccine research and manufacture using enhanced scientific / technical means and evolving enabling technologies, together with navigating pathways and regulatory processes to speed vaccine manufacturing diversity, capacity and availability.

Industry’s globally renowned congress
World Influenza Congress Europe is the influenza vaccine industry’s number one forum addressing identifying and addressing these critical issues and challenges for both the government as well as the vaccine and antiviral manufacturers across a global landscape.

The congress showcases all that is timely in the influenza vaccine industry right now. Capitalise on the opportunities and critical scientific developments that are presenting themselves across this therapeutic landscape. Register your attendance within the region’s must attend congress for vaccine representatives and drive your own influenza and antiviral developments beyond your peers.

Click to see the full speaker list »